Phase I study of hepatic arterial infusion chemotherapy with gemcitabine and 5FU for postoperative liver metastases from pancreatic cancer.
Phase 1
- Conditions
- Postoperative liver metastases from pancreatic cancer
- Registration Number
- JPRN-UMIN000011059
- Lead Sponsor
- Department of Gastroenterologic Surgery, Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Another metastases or not R0 resection case.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method adverse events
- Secondary Outcome Measures
Name Time Method